Robaxin and Ocrevus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Robaxin (methocarbamol) and Ocrevus (ocrelizumab). Common drug interactions include cyst rupture among females and muscular weakness among males.

The phase IV clinical study analyzes what interactions people have when they take Robaxin and Ocrevus. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

On Aug, 11, 2026

54 people who take Robaxin and Ocrevus together, and have interactions are studied.

What are the common drug interactions of Robaxin and Ocrevus, by gender? *:

female:

Cyst rupture (fluid leakage from sac)
Decreased appetite
Disturbance in attention
Drug hypersensitivity
Fatigue (feeling of tiredness)
Fall
Weight increased
Pain in extremity
Asthenia (weakness)
Insomnia (sleeplessness)

male:

Muscular weakness (muscle weakness)
Breast cancer
Chest pain
Dyspnoea (difficult or laboured respiration)
Fall
Palpitations (feelings or sensations that your heart is pounding or racing)
Cellulitis (infection under the skin)
Depression
Fatigue (feeling of tiredness)
Glucose urine present

What are the common drug interactions of Robaxin and Ocrevus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Breast abscess
Cellulitis (infection under the skin)
Depression
Drug hypersensitivity
Muscle tightness
Vitamin d decreased

30-39:

Memory impairment
Fall
Vision blurred
Asthenia (weakness)
Balance disorder
Blindness unilateral
Drug ineffective
Fatigue (feeling of tiredness)
Gait disturbance
Hypersomnia (excessive daytime sleepiness (eds))

40-49:

Fatigue (feeling of tiredness)
Migraine (headache)
Insomnia (sleeplessness)
Pain in extremity
Abdominal distension
Agitation (state of anxiety or nervous excitement)
Anger
Asthenia (weakness)
Bone pain
Confusional state

50-59:

General physical health deterioration (weak health status)
Hepatic steatosis (fatty liver disease)
Hepatomegaly (abnormal enlargement of the liver)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Hyperglycaemia (high blood sugar)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Intervertebral disc degeneration (spinal disc degeneration)
Intervertebral disc displacement
Microcytic anaemia (a generic term for any type of anaemia characterized by small red blood cells)
Muscular weakness (muscle weakness)

60+:

Fatigue (feeling of tiredness)
Neuralgia (pain in one or more nerves)
Pain in extremity
Urinary tract infection
Weight increased
Breast cancer
Depression
Glucose urine present
Muscular weakness (muscle weakness)
Nephrolithiasis (calculi in the kidneys)

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 24 people, 44.44%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 21 people, 38.89%
Pain: 15 people, 27.78%
Depression: 9 people, 16.67%
Stress And Anxiety: 7 people, 12.96%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 7 people, 12.96%
Neuropathy Peripheral (surface nerve damage): 7 people, 12.96%
Fatigue (feeling of tiredness): 6 people, 11.11%
Insomnia (sleeplessness): 6 people, 11.11%
Back Pain: 5 people, 9.26%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and Ocrevus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously